Episode
Semaglutide Shields Kidneys Too
- Published
- Jun 2, 2026
- Duration seconds
- 118
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/sydney-news-today-2-min-news-the-daily-news-now-7568669/episodes/semaglutide-shields-kidneys-too/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/sydney-news-today-2-min-news-the-daily-news-now-7568669/semaglutide-shields-kidneys-too.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Semaglutide, known for weight loss and diabetes control, is emerging as a game-changer for chronic kidney disease—new research shows it significantly improves kidney outcomes and survival, even in patients with heart failure. Building on earlier findings that it reduces heart attacks, strokes, and death, this latest data reveals its power to delay or prevent dialysis. Experts call it “highly kidney protective,” highlighting how managing diabetes and weight creates a ripple effect on kidney health. While the drug’s mechanism isn’t fully understood—likely tied to its appetite-suppressing effects—it may offer direct kidney benefits too. Caveats include industry funding and limited demographic diversity, but the evidence is mounting that GLP-1 agonists are becoming essential for heart, kidney, and overall health. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/4bb61450450501db